166 related articles for article (PubMed ID: 15226123)
1. HIV topical microbicides: steer the ship or run aground.
Gross M
Am J Public Health; 2004 Jul; 94(7):1085-9. PubMed ID: 15226123
[TBL] [Abstract][Full Text] [Related]
2. HIV topical microbicides: the current development strategy is fully justified.
Stone AB
Am J Public Health; 2004 Nov; 94(11):1845-6; author reply 1846-7. PubMed ID: 15514217
[No Abstract] [Full Text] [Related]
3. News from the Society for Women's Health Research: seeking effective topical microbicides.
Greenberger P
J Womens Health Gend Based Med; 2001 Mar; 10(2):99-100. PubMed ID: 11268294
[No Abstract] [Full Text] [Related]
4. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.
Braunstein S; van de Wijgert J
J Womens Health (Larchmt); 2005 Jun; 14(5):424-33. PubMed ID: 15989415
[TBL] [Abstract][Full Text] [Related]
5. The design of prophylactic trials for HIV: the case of microbicides.
Stein ZA; Myer L; Susser M
Epidemiology; 2003 Jan; 14(1):80-3; discussion 83-4. PubMed ID: 12500050
[No Abstract] [Full Text] [Related]
6. Will vaginal microbicides solve the HIV problem in Africa?
Muula AS
Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863
[No Abstract] [Full Text] [Related]
7. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
Madan RP; Keller MJ; Herold BC
Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
[TBL] [Abstract][Full Text] [Related]
8. Specific microbicides in the prevention of HIV infection.
Kelly CG; Shattock RJ
J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
[TBL] [Abstract][Full Text] [Related]
9. The slow evolution of microbicides for STD/HIV prevention.
Howes J; Bass M
J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
[No Abstract] [Full Text] [Related]
10. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
Olsen ML; Cwiak CA; Koudelka C; Jensen JT
Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
[TBL] [Abstract][Full Text] [Related]
11. Improving topical microbicide applicators for use in resource-poor settings.
Vail JG; Cohen JA; Kelly KL
Am J Public Health; 2004 Jul; 94(7):1089-92. PubMed ID: 15226124
[TBL] [Abstract][Full Text] [Related]
12. Vaginal microbicides: moving ahead after an unexpected setback.
van de Wijgert JH; Shattock RJ
AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
[No Abstract] [Full Text] [Related]
13. Vaginal microbicides: where are we and where are we going?
Moscicki AB
J Infect Chemother; 2008 Oct; 14(5):337-41. PubMed ID: 18936885
[TBL] [Abstract][Full Text] [Related]
14. The future of HIV microbicides: challenges and opportunities.
Garg AB; Nuttall J; Romano J
Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141
[TBL] [Abstract][Full Text] [Related]
15. Microbicides may be ready.
AIDS Patient Care STDS; 2002 May; 16(5):243. PubMed ID: 12055033
[No Abstract] [Full Text] [Related]
16. Re-framing microbicide acceptability: findings from the MDP301 trial.
Montgomery CM; Gafos M; Lees S; Morar NS; Mweemba O; Ssali A; Stadler J; Pool R;
Cult Health Sex; 2010 Aug; 12(6):649-62. PubMed ID: 20397079
[TBL] [Abstract][Full Text] [Related]
17. Microbicides--women pray for success.
Bateman C
S Afr Med J; 2006 Jun; 96(6):493-4. PubMed ID: 16841128
[No Abstract] [Full Text] [Related]
18. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
19. HIV/AIDS. At last, vaginal gel scores victory against HIV.
Cohen J
Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
[No Abstract] [Full Text] [Related]
20. Starting to gel.
Pilcher H
Nature; 2004 Jul; 430(6996):138-40. PubMed ID: 15241385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
